Elliott Management held talks with private equity groups in recent months to gauge interest in buying Bayer’s (BAYRY) consumer health business, ...

At the same time, Medical stocks have gained an average of 6.8%. This means that Bayer Aktiengesellschaft is performing better than its sector in terms of year-to-date returns.

Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...

Berlin: Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, have announced that they have ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bayer Aktiengesellschaft (BAYRY) been one of those stocks ...

A Georgia jury found pharmaceutical and agricultural products giant Bayer liable for more than $2 billion in damages to a plaintiff who argued that Roundup weed killer caused his cancer ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Bayer Aktiengesellschaft (BAYRY) been one of those stocks ...

Bayer obtains exclusive worldwide license for MTA-cooperative PRMT5 inhibitor for selective targeting of MTAP-deleted tumors ...

Bayer and Suzhou Puhe BioPharma Co. Ltd., a ... focusing on areas of highly unmet medical need." Protein arginine N-methyltransferase 5 (PRMT5) plays a crucial role in modifying proteins that ...